Advances in surgical procedures are opening up new opportunities to treat glaucoma, according to Iqbal Ike K. Ahmed, MD.
"We're really in a renaissance of surgical procedures," said Dr. Ahmed, medical director, Prism Eye Institute, and associate professor of ophthalmology, University of Toronto.
He gave an overview of glaucoma surgery options at the Glaucoma 360 22nd annual glaucoma CME program.
Until now, surgery has been considered a second-line treatment after medication and lasers because of the risks associated with trabeculectomy and tube shunts.
Now ophthalmologists can draw from a larger surgical tool chest. Dr. Ahmed divided these into internal microinvasive glaucoma surgery (MIGS), blebless ab-externo, bleb-forming with or without mitomycin c, and cycloablative.
"How do we get through all the options and where they may fit?" he asked. "For many of these options the data are limited."